Envista Holdings (NVST) Other Non-Current Liabilities (2018 - 2026)
Envista Holdings' (NVST) quarterly Other Non-Current Liabilities came in at $161.4 million in Q2 2026, up 9.42% year-on-year from $147.5 million in Q2 2025, and little changed quarter-over-quarter from $161.4 million in Q4 2025.
Envista Holdings (NVST) Other Non-Current Liabilities (2018 - 2026) Analysis & Trends
Envista Holdings' Other Non-Current Liabilities history runs 9 years deep, the most recent figure standing at $161.4 million for Q2 2026.
- On a quarterly basis, Other Non-Current Liabilities rose 9.42% year-over-year to $161.4 million in Q2 2026; TTM through Apr 2026 was $161.4 million, a 9.42% increase from a year earlier, with the FY2025 full-year figure at $161.4 million, up 15.45% from the prior year.
- Other Non-Current Liabilities steadied at $161.4 million in Q2 2026 per NVST's latest filing, from $161.4 million in the prior quarter.
- Across five years, Other Non-Current Liabilities topped out at $288.2 million in Q2 2022 and bottomed at $136.7 million in Q1 2024.
- The 5-year median for Other Non-Current Liabilities is $151.3 million (2022), against an average of $167.3 million.
- Across the five-year window, Other Non-Current Liabilities tumbled 51.53% in 2022 and increased 16.2% in 2025, its largest moves.
- Year by year, Other Non-Current Liabilities stood at $151.3 million in 2022, then dropped by 5.88% to $142.4 million in 2023, then dropped by 1.83% to $139.8 million in 2024, then gained by 15.45% to $161.4 million in 2025, then changed by 0.0% to $161.4 million in 2026.
- Per Business Quant, the three latest NVST Other Non-Current Liabilities figures stand at $161.4 million (Q2 2026), $161.4 million (Q4 2025), and $169.7 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn |
| 10 | Envista Holdings | 4.29 Bn | 3.20 Bn | 390.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | 161.40 Mn |
| Dec 31, 2025 | 161.40 Mn |
| Sep 26, 2025 | 169.70 Mn |
| Jun 27, 2025 | 171.40 Mn |
| Mar 28, 2025 | 147.50 Mn |
| Dec 31, 2024 | 139.80 Mn |
| Sep 27, 2024 | 149.70 Mn |
| Jun 28, 2024 | 147.50 Mn |
| Mar 29, 2024 | 136.70 Mn |
| Dec 31, 2023 | 142.40 Mn |
| Sep 29, 2023 | 150.50 Mn |
| Jun 30, 2023 | 153.00 Mn |
| Mar 31, 2023 | 151.30 Mn |
| Dec 31, 2022 | 151.30 Mn |
| Sep 30, 2022 | 220.70 Mn |
| Jul 1, 2022 | 201.30 Mn |
| Apr 1, 2022 | 288.20 Mn |
| Dec 31, 2021 | 304.20 Mn |
| Oct 1, 2021 | 318.20 Mn |
| Jul 2, 2021 | 415.30 Mn |